CRC News: June 18, 2024
Welcome to the latest edition of CRC News, the American Cancer Society National Colorectal Cancer Roundtable (ACS NCCRT) periodic newsletter for ACS NCCRT members and partners working toward our shared goal to reach 80% in Every Community.
ACS NCCRT’s Latest Resource Released!
Delve into the CRC Data Dashboard, an Interactive Mapping Tool to Explore Colorectal Cancer Data
We are excited to announce the release of the ACS NCCRT’s latest resource: the CRC Data Dashboard. This new mapping tool offers an interactive geospatial view of data pertaining to colorectal cancer in the United States. The dynamic national platform integrates layers from multiple sources and allows you to interactively explore data using maps and graphs, including:
- CRC surveillance data (incidence rates, mortality rates)
- CRC screening rates
- Healthcare settings (Commission of Cancer hospitals, Federally Qualified Health Centers, National Cancer Institute Designated Cancer Centers)
- Demographics (age, race and Hispanic origin, poverty status, educational attainment)
- Additional health measures (smoking prevalence, obesity)
These maps can be used by researchers, public health professionals, policymakers, and others to understand and illustrate the burden of colorectal cancer in communities across the United States and assist in planning and tailoring interventions.
Spread the Word:
We encourage you to share this new resource with your partners. Retweet from @NCCRTnews and share our posts on LinkedIn.
Join us on July 25, 2024, from 1:00-2:00 PM ET to learn how to use the tool and hear an example of how mapping tools like this can be used to tailor interventions to increase colorectal cancer screening and impact outcomes in local areas. Register now to reserve your spot in this program.
We would like to share a special thanks to the members of the American Cancer Society’s Geospatial Solutions Team, led by Dr. Liora Sahar, who generously dedicated their time and expertise to the development of this new resource.
We are excited to see how you use CRC Data Dashboard to reach the communities you serve.
Join the American Cancer Society for an ECHO Series on Pediatric, Adolescent and Young Adult Cancer Survivorship
The Year Long ECHO Series is Free and Offers CME Credits
Each year in the United States, over 95,000 children, teens, and young adults are diagnosed with cancer before the age of forty. While 85% of these individuals survive for at least five years, they often face long-term effects from their illness and treatments. Many healthcare providers may not be fully aware of the unique post-treatment survivorship issues and optimal care strategies for this population. Our collaborative sessions aim to deepen understanding of the specific needs of pediatric, adolescent, and young adult cancer survivors and promote robust discussions among oncology and primary care providers on effective care strategies.
Through a series of virtual ECHO sessions, attendees will:
- Increase knowledge of the late effects of pediatric, adolescent, and young adult cancers and their treatments.
- Enhance confidence in addressing gaps in care for these survivors.
- Raise awareness of various survivorship care models.
The series will include 12 monthly sessions from June 26, 2024 to May 28, 2025, and the target audience includes physicians (primary care and family medicine), advanced practice providers, nurses, social workers, patient navigators, and other healthcare providers involved in the care of pediatric, adolescent, and young adult cancer survivors.
ICYMI: New Resources to Reach LGBTQ+ Communities for Colorectal Cancer Screening
Celebrate Pride Month by Learning More About How to Impact LGBTQ+ Communities
People who identify as lesbian, gay, bisexual, transgender, queer, questioning, or other diverse sexual orientations or gender identities (LGBTQ+) face barriers that make them less likely to get screened for colorectal cancer than the general population. Review and share the following two new resources to promote colorectal cancer screening in LGBTQ+ communities this month:
- In a first-of-its-kind study, the American Cancer Society on May 31 released “Cancer in People who Identify as Lesbian, Gay, Bisexual, Transgender, Queer or Gender-nonconforming (LGBTQ+)”. The article provides the latest statistics on the prevalence of cancer screening and modifiable risk factors in LGBTQ+ populations, as well as a review of literature on cancer occurrence and obstacles to cancer prevention and treatment. These important findings are published in the journal Cancer, alongside its consumer-friendly companion, Cancer Facts & Figures 2024 Special Section: Cancer in People Who Identify as Lesbian, Gay, Bisexual, Transgender, Queer, or Gender-nonconforming.
- At the end of May, the ACS NCCRT released a newly updated brief that describes this community’s unique barriers to colorectal cancer screening and outlines action steps to support colorectal cancer screening in LGBTQ+ communities. It is intended for community-based organizations, health systems, and other organizations to use to better understand and serve LGBTQ+ members of their community.
23andMe and the Colorectal Cancer Alliance Collaborate to Help Advance Colorectal Cancer Research in the Black Community
Study aims to fill research gap and empower people through access to information about their health
23andMe Holding Co., a leading genetic health and biopharmaceutical company, and the Colorectal Cancer Alliance, the largest nonprofit organization dedicated to ending colorectal cancer and a member of the ACS NCCRT, announced a collaboration to help advance research on colorectal cancer in the Black/African American community. The Genetic Insights into Colorectal Cancer in the Black Community Study is part of 23andMe’s continued efforts to raise awareness about important health conditions that touch many individuals but disproportionately impact the Black community.
Upcoming Member & Partner Events:
Register and Save the Date for these Upcoming Programs
- Register here to join the American Cancer Society, the Centers for Disease Control and Prevention, Kaiser Permanente Center for Health Research and members of the African Methodist Episcopal (AME) church for a webinar on Wednesday, July 17, 2024, from 1-2pm ET to learn more about how to promote colorectal cancer screening in the AME church community.
- Registration is open for the American Cancer Society’s new summer webinar series focused on cancer care across the continuum and coalitions. Two webinars are left in the series:
- Overcoming Stigma as a Barrier to Equitable Lung Cancer Care (In partnership with the ACS National Lung Cancer Roundtable) on July 10, 2024, from 1-2 PM ET
- Promoting Non-Invasive Colorectal Cancer Screening (In partnership with the ACS NCCRT) on August 14, 2024, 1-2 PM ET
- Registration is now open for the third annual Western Colorectal Cancer Consortium Conference on September 26-27, 2024, in Davis, CA. Poster abstract submissions are being accepted now through September 6, 2024. Register by August 2, 2024, to receive the early bird rate.
Many thanks for the great work you do!
The ACS NCCRT Team
Do you have a colleague that would like to be added to receive our newsletter? Please encourage them to sign up to receive CRC News by following the link and scrolling to the bottom of the page to fill out the contact form.
We Highlight Successes, Leaders, Best Practices, And Tools That Are Making An Impact In The Nationwide Movement To Reach 80% Screened For Colorectal Cancer.
Do you have a suggestion for a future blog topic? We welcome you to share your suggestions by emailing [email protected].
Blog Policy
Opinions expressed in these blog posts are that of the author and do not represent policies of the National Colorectal Cancer Roundtable or the author’s institution.
Our staff moderate all comments on the 80% Blog. While we do not censor based on point of view, we will delete or edit comments that are offensive or off topic. Click here to view full version.
Featured Blog Posts
© 2024 American Cancer Society National Colorectal Cancer Roundtable. All rights reserved.